US researchers behind the new analysis said they hoped the findings would help patients weigh up the potential benefits of ...

The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

In the last 5 years significant progress has been made in potential dementia treatments, yet many of these treatments come ...

NCT01767194 Irinotecan hydrochloride and temozolomide with temsirolimus or monoclonal antibody Ch14.18 in treating ... Austria NCT01701479 Long term continuous infusion ch14.18/CHO plus s.c ...

1 BRIUMVI® is a novel monoclonal ... on the antibody. Removal of these sugar molecules, a process called glycoengineering, allows for efficient B-cell depletion.2 In clinical studies, patients who ...

Despite its extensive use and popularity, aspartame has become a source of controversy in recent years, with some research suggesting the sweetener has adverse health effects. It is not clear if ...

And it's all because of an unexpected side effect that has arguably saved her life. 'I had been in and out of hospitals for years,' recalls Hannah. 'At 15 I was diagnosed with anxiety, then ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

Monoclonal antibodies are immune system proteins that ... Of those who did pay out-of-pocket costs, 80% paid between $0.01 and $925 per infusion, after paying the deductible.